跳转至内容
Merck
CN
所有图片(1)

主要文件

查看所有文档

安全信息

5.00936

SAFC

维生素 D₃（胆钙化醇）晶体（1 g = 40 Mio.I.U.）

EMPROVE® ESSENTIAL, Ph. Eur., BP, USP

制药生产

别名:

Vitamin D₃ (cholecalciferol) cryst. (1 g = 40 Mio.I.U.), Colecalciferol, Cholecalciferol

登录查看公司和协议定价
所有图片(1)

About This Item

CAS号:
67-97-0
分子量:
384.64
MDL编号:
MFCD00078131
UNSPSC代码:
12352401
EC索引号:
200-673-2

Agency

BP
Ph. Eur.
USP

质量水平

500

产品线

EMPROVE® ESSENTIAL

表单

solid

mp

82-87 °C

溶解性

<0.1 g/L

应用

liquid formulation
pharmaceutical

储存温度

2-8°C

SMILES字符串

O[C@H]1CCC(=C)\C(=C\C=C2\[C@H]3[C@@]([C@H](CC3)[C@@H](CCCC(C)C)C)(CCC\2)C)\C1

InChI

1S/C27H44O/c1-19(2)8-6-9-21(4)25-15-16-26-22(10-7-17-27(25,26)5)12-13-23-18-24(28)14-11-20(23)3/h12-13,19,21,24-26,28H,3,6-11,14-18H2,1-2,4-5H3/b22-12+,23-13+/t21-,24+,25-,26+,27-/m1/s1

InChI key

QYSXJUFSXHHAJI-FVUVGDFOSA-N

一般描述

We offer a range of high quality critical raw materials, solvents and reagents plus the documentation and expertise to meet stringent regulatory requirements. In addition to our comprehensive portfolio, we also offer custom manufacturing services to meet your exact needs. As part of our Emprove® Program, our raw materials are offered with extensive documentation facilitating compliance of your pharma and biopharma product, full supply chain transparency and risk mitigation. Our SAFC® portfolio of high-quality products for biopharmaceutical and pharmaceutical formulation and production withstands strict quality control procedures and is produced according to applicable cGMP guidelines.

应用

Vitamin D3 is used in clinical nutrition for treatment of vitamin D3 deficiency and as skincare agent. Vitamin D3 Emprove® Essential is suitable for pharmaceutical applications.

法律信息

Emprove is a registered trademark of Merck KGaA, Darmstadt, Germany
SAFC is a registered trademark of Merck KGaA, Darmstadt, Germany

象形图

Skull and crossbonesHealth hazard
GHS06,GHS08

警示用语：

Danger

危险分类

Acute Tox. 2 Dermal - Acute Tox. 2 Inhalation - Acute Tox. 2 Oral - STOT RE 1 Oral

储存分类代码

6.1A - Combustible acute toxic Cat. 1 and 2 / very toxic hazardous materials

WGK

WGK 2

闪点(°F)

Not applicable

闪点(°C)

Not applicable

法规信息

新产品

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Strategies for the Development of Safe and Effective Pediatric Formulations

Medicine for children poses unique formulation challenges compared to adults. Consider developmental physiology and age specifics when designing pharmaceuticals. Quality issues can severely impact patient safety. Therefore, excipient quality, supplier selection, and supply chain security are crucial, particularly for pediatric formulations.

相关内容

Pediatric Formulations

Developing formulations specifically for infants and children is increasingly important. To help you master these challenges effectively, we offer an extensive portfolio of well-established high-quality excipients and APIs for pediatric pharmaceutical formulations that are proven in practice.

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门